-
Clinical Development of Gene Therapy Products for Rare Diseases
Clinical Development of Gene Therapy Products for Rare Diseases
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to the clinical […]